Extravasation of leukocytes in comparison to tumor cells
暂无分享,去创建一个
[1] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[2] W. Muller,et al. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. , 1996, Journal of immunology.
[3] Klaus Ley,et al. CD24 mediates rolling of breast carcinoma cells on P‐selectin , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] H. Broxmeyer. Chemokines in hematopoiesis , 2008, Current opinion in hematology.
[5] B. Yard,et al. Modulation of chemokine production and expression of adhesion molecules in renal tubular epithelial and endothelial cells by catecholamines , 2002, Transplantation.
[6] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[7] T. Springer,et al. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. , 1995, Immunology today.
[8] F. Luscinskas,et al. Endothelial-Dependent Mechanisms of Leukocyte Recruitment to the Vascular Wall , 2007, Circulation research.
[9] R. Lotan,et al. Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion , 1994, Glycoconjugate Journal.
[10] V. Kuchroo,et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity , 2005, Nature Immunology.
[11] M. Teitell,et al. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. , 2004, The American journal of pathology.
[12] M. Cybulsky,et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.
[13] R. Sackstein. The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. , 2004, The journal of investigative dermatology. Symposium proceedings.
[14] J. Hirabayashi,et al. A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. , 2003, The American journal of pathology.
[15] S. Hwang,et al. Chemokines, chemokine receptors, and cancer metastasis , 2006, Journal of leukocyte biology.
[16] P. Altevogt,et al. The L1 adhesion molecule is a cellular ligand for VLA-5 , 1995, The Journal of cell biology.
[17] S. Barthel,et al. Targeting selectins and selectin ligands in inflammation and cancer , 2007, Expert opinion on therapeutic targets.
[18] N. Chen,et al. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. , 2005, Molecular biology of the cell.
[19] D. Vestweber. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium , 2007, Immunological reviews.
[20] Hiroto Kawashima,et al. Roles of sulfated glycans in lymphocyte homing. , 2006, Biological & pharmaceutical bulletin.
[21] W. Muller,et al. CD99 plays a major role in the migration of monocytes through endothelial junctions , 2002, Nature Immunology.
[22] J. Becker,et al. Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3 , 1996, The Journal of cell biology.
[23] S. Shimizu,et al. CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. , 2008, Cancer research.
[24] S. Rosen,et al. Commentary Endothelial Ligands for L-Selectin From Lymphocyte Recirculation to Allograft Rejection , 1999 .
[25] B. Imhof,et al. Vascular and epithelial junctions: a barrier for leucocyte migration. , 2008, Biochemical Society transactions.
[26] K. Konstantopoulos,et al. Variant isoforms of CD44 are P‐ and L‐selectin ligands on colon carcinoma cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] F. Entschladen,et al. Surface molecules regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-MB-468 breast carcinoma cells and their interaction , 2007, Cellular and Molecular Life Sciences.
[28] N. Matthews,et al. Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. , 1993, Immunology.
[29] W. Hatzmann,et al. Realtime visualization of tumor cell/endothelial cell interactions during transmigration across the endothelial barrier , 2002, Journal of Cancer Research and Clinical Oncology.
[30] J. Hirabayashi,et al. Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion* , 2007, Journal of Biological Chemistry.
[31] J. Hogg,et al. Neutrophil kinetics in rabbits during infusion of zymosan-activated plasma. , 1989, Journal of applied physiology.
[32] A. Griffioen,et al. Galectins in the tumor endothelium: opportunities for combined cancer therapy. , 2007, Blood.
[33] J. Hogg,et al. Marginated pool of neutrophils in rabbit lungs. , 1987, Journal of applied physiology.
[34] E. Waubant,et al. T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.
[35] W. Aird. Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds , 2007, Circulation research.
[36] K. Pienta,et al. Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. , 2005, Cancer research.
[37] A. Montgomery,et al. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. , 2001, Molecular biology of the cell.
[38] D. Vestweber,et al. A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo. , 2007, Blood.
[39] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[40] J. Hogg,et al. Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung. , 1993, Journal of applied physiology.
[41] H. Chen,et al. Differential movements of VE-cadherin and PECAM-1 during transmigration of polymorphonuclear leukocytes through human umbilical vein endothelium. , 2002, Blood.
[42] F. Sarkar,et al. Galectin-3 and L1 retrotransposons in human breast carcinomas , 1998, Breast Cancer Research and Treatment.
[43] M. Ghazizadeh,et al. T/Tn pancarcinoma autoantigens: fundamental, diagnostic, and prognostic aspects. , 1995, Cancer detection and prevention.
[44] David R. Nadeau,et al. Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Fukuda,et al. Nepmucin, a novel HEV sialomucin, mediates L-selectin–dependent lymphocyte rolling and promotes lymphocyte adhesion under flow , 2006, The Journal of experimental medicine.
[46] G. Rabinovich. Galectin-1 as a potential cancer target , 2005, British Journal of Cancer.
[47] William C. Aird,et al. Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms , 2007, Circulation research.
[48] S. Cunningham,et al. Cloning of Human Junctional Adhesion Molecule 3 (JAM3) and Its Identification as the JAM2 Counter-receptor* , 2001, The Journal of Biological Chemistry.
[49] I. Campbell,et al. Transmembrane and cytoplasmic domains in integrin activation and protein-protein interactions (Review) , 2008, Molecular membrane biology.
[50] J. Foidart,et al. Expression of Lamp‐1 and Lamp‐2 and their interactions with galectin‐3 in human tumor cells , 1998, International journal of cancer.
[51] E. Butcher,et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues , 2005, Nature Immunology.
[52] T. Kinashi,et al. Intracellular signalling controlling integrin activation in lymphocytes , 2005, Nature Reviews Immunology.
[53] S. Deutscher,et al. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. , 2001, Cancer research.
[54] M. Arnaout,et al. Integrin structure, allostery, and bidirectional signaling. , 2005, Annual review of cell and developmental biology.
[55] G. Downey,et al. Neutrophil sequestration and migration in localized pulmonary inflammation. Capillary localization and migration across the interalveolar septum. , 1993, The American review of respiratory disease.
[56] K. Konstantopoulos,et al. Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells , 2006, Journal of Biological Chemistry.
[57] Carlo Laudanna,et al. Rapid leukocyte integrin activation by chemokines , 2002, Immunological reviews.
[58] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[59] K. Dib,et al. BETA 2 integrin signaling in leukocytes. , 2000, Frontiers in bioscience : a journal and virtual library.
[60] K. Miyake,et al. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. , 1994, Cancer research.
[61] Gabriel A. Rabinovich,et al. Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.
[62] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[63] B. Engelhardt,et al. Mini‐review: Transendothelial migration of leukocytes: through the front door or around the side of the house? , 2004, European journal of immunology.
[64] S. Deutscher,et al. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. , 2000, Cancer research.
[65] Peter Friedl,et al. Interstitial leukocyte migration and immune function , 2008, Nature Immunology.
[66] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[67] Kerstin Lang,et al. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.
[68] K. Konstantopoulos,et al. Carcinoembryonic Antigen and CD44 Variant Isoforms Cooperate to Mediate Colon Carcinoma Cell Adhesion to E- and L-selectin in Shear Flow* , 2008, Journal of Biological Chemistry.
[69] R. Sackstein. The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. , 2004, The Journal of investigative dermatology.
[70] A. Varki,et al. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. , 1999, The American journal of pathology.
[71] V. Castronovo,et al. Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell–cell adhesion , 2004, Angiogenesis.
[72] C. Carman,et al. Structural basis of integrin regulation and signaling. , 2007, Annual review of immunology.
[73] E. Dejana,et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. , 1995, Cancer research.
[74] S. Hemmerich,et al. Sulfation-dependent recognition of high endothelial venules (HEV)- ligands by L-selectin and MECA 79, and adhesion-blocking monoclonal antibody , 1994, The Journal of experimental medicine.
[75] M. Perretti,et al. Inhibitory control of endothelial galectin‐1 on in vitro and in vivo lymphocyte trafficking , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[76] D. Adams,et al. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. , 1993, Immunology today.
[77] Kenneth L. van Golen,et al. Stepping out of the flow: capillary extravasation in cancer metastasis , 2007, Clinical & Experimental Metastasis.
[78] L. Monteiro,et al. A theoretical model for estimating the margination constant of leukocytes , 2002, BMC Physiology.
[79] G. Rådegran,et al. Alterations in the rheological flow profile in conduit femoral artery during rhythmic thigh muscle contractions in humans. , 2005, The Japanese journal of physiology.
[80] S. Hemmerich,et al. Binding of L-selectin to the vascular sialomucin CD34. , 1993, Science.
[81] A. Varki,et al. L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. , 2006, Cancer research.
[82] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[83] S. Watson,et al. An endothelial ligand for L-Selectin is a novel mucin-like molecule , 1992, Cell.
[84] R. Roth,et al. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. , 2000, Pharmacological reviews.
[85] D. Vestweber,et al. Junctional adhesion molecules (JAMs): more molecules with dual functions? , 2004, Journal of Cell Science.
[86] A. Zernecke,et al. JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.
[87] C. E. van der Schoot,et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. , 1996, The American journal of pathology.
[88] R. Hughes. Galectins as modulators of cell adhesion. , 2001, Biochimie.
[89] M. Philippova,et al. Structure and Functions of Classical Cadherins , 2001, Biochemistry (Moscow).
[90] A. Félix,et al. Simple mucin‐type carbohydrate antigens (T, Tn and sialosyl‐Tn) in mucoepidermoid carcinoma of the salivary glands , 1994, Histopathology.
[91] T. L. Drell,et al. The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockers , 2006, International journal of cancer.
[92] James J. Campbell,et al. Cutting Edge: Chemokine Receptor CCR4 Is Necessary for Antigen-Driven Cutaneous Accumulation of CD4 T Cells under Physiological Conditions1 , 2007, The Journal of Immunology.
[93] P. Kubes,et al. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action , 2003, Thrombosis and Haemostasis.
[94] Gerhard Christofori,et al. Changing neighbours, changing behaviour: cell adhesion molecule‐mediated signalling during tumour progression , 2003, The EMBO journal.
[95] Julia T. Chu,et al. HCELL Is the Major E- and L-selectin Ligand Expressed on LS174T Colon Carcinoma Cells* , 2006, Journal of Biological Chemistry.
[96] M. Miyasaka,et al. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas , 2004, Nature Reviews Immunology.
[97] A. Benner,et al. Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. , 2006, Cancer research.
[98] C. Doig,et al. Functional α4-integrin: A newly identified pathway of neutrophil recruitment in critically ill septic patients , 2001, Nature Medicine.
[99] G. Rabinovich,et al. Shedding light on the immunomodulatory properties of galectins: Novel regulators of innate and adaptive immune responses , 2004, Glycoconjugate Journal.
[100] L. Piccio,et al. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. , 2000, Immunity.
[101] M. Hirashima,et al. Human Ecalectin, a Variant of Human Galectin-9, Is a Novel Eosinophil Chemoattractant Produced by T Lymphocytes* , 1998, The Journal of Biological Chemistry.
[102] E. Dejana,et al. Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.
[103] B. Petri,et al. Molecular events during leukocyte diapedesis , 2006, The FEBS journal.
[104] Cheng Zhu,et al. A catch to integrin activation , 2007, Nature Immunology.
[105] Sachiko Sato,et al. Role of Galectin-3 in Leukocyte Recruitment in a Murine Model of Lung Infection by Streptococcus pneumoniae1 , 2008, The Journal of Immunology.
[106] W. Muller. The role of PECAM‐1 (CD31) in leukocyte emigration: studies in vitro and in vivo , 1995, Journal of leukocyte biology.
[107] D. Phillips,et al. PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.
[108] C. Qualls,et al. Cell Adhesion Molecules—Update , 1997, Veterinary pathology.
[109] N. Dolloff,et al. CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells , 2004, Cancer Research.
[110] Lu-Gang Yu. The oncofetal Thomsen–Friedenreich carbohydrate antigen in cancer progression , 2007, Glycoconjugate Journal.
[111] F. Entschladen,et al. The cancer's nervous tooth: Considering the neuronal crosstalk within tumors. , 2008, Seminars in cancer biology.
[112] J. Van Damme,et al. The role of CXC chemokines and their receptors in cancer. , 2008, Cancer letters.
[113] D. Hsu,et al. Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death1 , 2006, The Journal of Immunology.
[114] G. Glinsky,et al. MDA-MB-435 Human Breast Carcinoma Cell Homo- and Heterotypic Adhesion under Flow Conditions Is Mediated in Part by Thomsen-Friedenreich Antigen-Galectin-3 Interactions* , 2003, The Journal of Biological Chemistry.
[115] M. Perretti,et al. Novel insights into the inhibitory effects of Galectin‐1 on neutrophil recruitment under flow , 2008, Journal of leukocyte biology.
[116] B. Brandt,et al. 3D-extravasation model -- selection of highly motile and metastatic cancer cells. , 2005, Seminars in cancer biology.
[117] C. Gahmberg,et al. Specific integrin alpha and beta chain phosphorylations regulate LFA-1 activation through affinity-dependent and-independent mechanisms , 2022 .
[118] S. Fagerholm,et al. Specific integrin α and β chain phosphorylations regulate LFA-1 activation through affinity-dependent and -independent mechanisms , 2005, The Journal of cell biology.
[119] S. Hemmerich,et al. Induction of PNAd and N-acetylglucosamine 6-O-sulfotransferases 1 and 2 in mouse collagen-induced arthritis , 2006, BMC Immunology.
[120] F. Luscinskas,et al. CD99 Is a Key Mediator of the Transendothelial Migration of Neutrophils1 , 2007, The Journal of Immunology.
[121] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[122] T. L. Drell,et al. Effects of Neurotransmitters on the Chemokinesis and Chemotaxis of MDA-MB-468 Human Breast Carcinoma Cells , 2003, Breast Cancer Research and Treatment.
[123] A. Al-Mehdi,et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.